Journals
RSS Feed Readers

Filter by Tag:   Date:
Journals
02
Aug

Anavex Presents Preclinical Data for Alzheimer's Lead Compounds

Posted by: Admin

Anavex Life Sciences Corp., recently presented data on two of its investigational drug candidate namely ANAVEX 2-73 and ANAVEX 1-41 for Alzheimer’s...Read More

04
Jul

A New Class of Sleeping Pills Being Developed by Merck

Posted by: Admin

Merck after Spending Eight Year Develops a New Sleep Pill with Different Mechanism of Action from Existing Drugs According to Merck, it has spent...Read More

29
Jun

Scientists Report a Novel Memory Enhancing Drug

Posted by: Admin

S 18986: Selective Positive Allosteric Modulator of AMPA-Type Glutamate Receptors Improves Memory According to a recent study, “Alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic...Read More

27
Jun

Scientists at Pfizer report New Data in Antipsychotic Medicine Ziprasidone

Posted by: Admin

Ziprasidone: Effective Alternative for Quetiapine In Case Of Weight Gain or Lack of Tolerability Recent study in schizophrenia, “Switching from...Read More

24
Jun

Serdaxin for Major Depressive Disorder, Phase 2b Patient Recruitment Completed

Posted by: Admin

Rexahn Pharmaceuticals Completes Patient Recruitment for Phase 2b trial of Serdaxin for MDD Phase IIb trial patient recruitment, to evaluate Serdaxin...Read More

23
Jun

Phase 2b Study Begun For ASD drug Arbaclofen

Posted by: Admin

Seaside Inc. Begins Phase 2b clinical trial of STX209 (Arbaclofen) for Autism Spectrum Disorders (ASD) Autism Spectrum Disorders (ASD) is a neurodevelopmental...Read More

15
Jun

Novel Medication for Treatment-Resistant Depression Enters Clinical Phase

Posted by: Admin

Depression is a serious and chronic disease and the right medication for many patients has remained elusive, for long .   Lately, Alkermes,...Read More

14
Jun

First Potassium Channel Opener Approved for Use in Epilepsy

Posted by: Admin

U.S. FDA Gives Its Approval for Potiga (Ezogabine) To Treat Seizures in Adults U.S. Food and Drug Administration recently approved an add-on medication...Read More

13
Jun

Levodopa-Carbidopa Intestinal Gel Shows Positive Phase III Results

Posted by: Admin

Investigational Treatment For Advanced Parkinson's Disease Shows Positive Results According to Abbott Laboratories, the U.S. health care major, its investigational...Read More

11
Jun

Now Quit Smoking without Gaining Weight

Posted by: Admin

Recent Discovery May Facilitate Quitting Smoking Without Gaining Weight   Recent research led by a team of scientists from Yale school of medicine...Read More

Journals are primarily meant for Medical practitioners and healthcare service providers to find out what’s new and happening in the medical world. Latest scientific breakthroughs, research, events and conferences will all be there for you. This section of HealthLine 24x7 will ensure that you are constantly updated on the latest discovery, innovation and experiment. You can browse through the journal content available on HealthLine 24x7 either date wise or category wise. The current categories available are Cardiology, Neurology and Oncology. The few journals available on Healthline24x7 currently are, “Alzheimer and Heart Disease Share a Common Gene according To the Latest Research,” “A Ray of Hope for Patients with Severe Aortic Stenosis,” “Vioxx and Heart Attack-The Mystery Solved,” “Repairing Damaged Hearts, Naturally,” “To Get A Mammogram Or Not.”